Taurine Prevents Impairments in Skin Barrier Function and Dermal Collagen Synthesis Triggered by Sleep Deprivation-Induced Estrogen Circadian Rhythm Disruption

The human keratinocyte cell line (HaCaT) and mouse fibroblast cell lines (NIH 3T3) were obtained from Pronocell Biotech Co., Ltd. (Wuhan, China). Cells were grown in Dulbecco's Modified Eagle Medium (DMEM) (C11995500BT, Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (FSD500, ExCell Bio, Shanghai, China). The cells were cultivated at 37 °C in a humidified environment with 5% CO₂ in a cell culture incubator. Cell passages were digested using 0.25% trypsin (25200072, Gibco, Grand Island, NY, USA). Estradiol (HY-B0141, MedChemExpress, Monmouth Junction, NJ, USA) was administered at concentrations of 0.1, 1, and 10 nM for 24 h, while taurine (HY-B0351, MedChemExpress, Monmouth Junction, NJ, USA) was administered at concentrations of 0.1, 1, and 10 μM for 24 h. Fulvestrant (HY-13636, MedChemExpress, Monmouth Junction, NJ, USA) at 1 μM was added 4 h prior to the administration of other drugs, which were applied concomitantly in the presence of fulvestrant. Additionally, the cells were starved for 12 h in DMEM without FBS before administering the drug treatments.

Tissues and cells were treated with TRIzol reagent (15596026, Invitrogen, Carlsbad, CA, USA) to extract total RNA. A reverse transcription kit (RR036A, Takara, Tokyo, Japan) was then used to transform the RNA into cDNA. The ChamQ SYBR qPCR Master Mix (Q311-02, Vazyme, Nanjing, China) was used to conduct quantitative real-time PCR (qRT-PCR) on a CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The reference gene, either GAPDH or β-actin, was used to standardize the levels of gene expression. To analyze the data, the 2^−ΔΔCt method was used. The primers for qPCR were designed based on coding sequences obtained from NCBI, using Primer-BLAST. Table 1 contains the list of primers used in qRT-PCR.

RIPA lysis buffer (FD008, Fidelity Bio, Hangzhou, China) combined with 0.1 mM PMSF (FD0100, Fidelity Bio, Hangzhou, China) was used to extract proteins from cells and skin tissues. Protein supernatants were obtained by centrifugation at 12,000 rpm, and protein content was quantified using the BCA Protein Assay Kit (23225, Thermo Fisher Scientific, Waltham, MA, USA). SDS-PAGE was used to separate the proteins, which were then moved to a PVDF membrane (10600021, Cytiva, Marlborough, MA, USA) and blocked for 1 h at room temperature using 5% bovine serum albumin (BSA) (9048-46-8, Aladdin, Ontario, CA, USA). After that, primary antibodies were placed on the membrane for an entire night at 4 °C, and secondary antibodies were incubated for 1 h at room temperature. Primary and secondary antibodies are listed in Table 2. Target proteins were visualized using ECL Western Blotting substrate (K12045D50, Advansta, San Jose, CA, USA). The intensity of the bands for each protein was quantified using Image J software (1.49v, National Institutes of Health, Bethesda, MD, USA).

HaCaT cells were seeded at a density of 1 × 10⁵ cells per well onto Transwell^® chambers with a 0.4 µm pore size polyester membrane (3470, Corning Incorporated, Corning, NY, USA) and treated in accordance with different experimental requirements. The integrity of the cell monolayer was assessed by measuring the Transepithelial Electrical Resistance (TEER) using the Millicell ERS system (Millipore, Bedford, MA, USA). The TEER value for each sample was calculated as follows: TEERsample (Ω·cm²) = (Rsample − Rblank) (Ω) × effective membrane area (cm²).

The pcDNA3.1 overexpression plasmid was constructed and transfected for 48 h using Lipofectamine 3000 (L3000015, Thermo Fisher, Waltham, MA, USA) as the transfection reagent according to the instruction manual. Lipofectamine RNAiMAX (13778100, Thermo Fisher, Waltham, MA, USA) was used to deliver siRNA for 60 h. Table 3 lists the primers used.

HaCaT and NIH 3T3 cells were inoculated into 96-well plates and treated with different concentrations of test compounds for 12 h. Calcium levels were measured using a calcium detection assay kit (36310, AAT Bioquest, Pleasanton, CA, USA) according to the manufacturer's instructions. After treatment with Calbryte^TM520AM (1:500 dilution) for 30 min at 37 °C, free Ca²⁺ was washed with HHBS. Changes in calcium ion fluorescence were immediately detected in real time using a full-featured fluorescence enzyme marker (Synergy H1). For stimulation of Ca²⁺ release, 200 μM adenosine triphosphate (ATP) was injected into cultures. Photographs were taken using a laser scanning confocal microscope (Zeiss, LSM 900, Oberkochen, Germany) at an excitation wavelength of 529 nm.

HaCaT and NIH 3T3 cells were inoculated into 20 mm diameter confocal culture dishes at a density of 1.5 × 10⁵ cells per dish. After attachment, cells were treated with estradiol, taurine, or calcium-free medium (Ca²⁺ free) for 24 h. Following a 10-min fixation with 4% paraformaldehyde (PFA), the cells were rinsed three times for 3 min each with PBS. At room temperature, they were blocked for 1 h using 5% BSA. Subsequently, primary antibodies against ZO-1 (Ab221547, Abcam, Cambridge, MA, USA), occludin (Ab216327, Abcam, Cambridge, MA, USA), and Collagen III (EPR17673, Abcam, Cambridge, MA, USA) at a dilution of 1:200 were incubated at 4 °C overnight. Following a PBS wash, cells were treated for 1 h at room temperature with Alexa Fluor^® 594 (Ab150080, Abcam, Cambridge, MA, USA) or Alexa Fluor^® 488 (Ab150077, Abcam, Cambridge, MA, USA) secondary antibodies (dilution 1:200). The nuclei were then stained with DAPI (AR1177, Boster Bio, Pleasanton, CA, USA). Lastly, the LSM900 confocal microscope (Zeiss, Oberkochen, Germany) was used to observe the cells.

Animal Skin Tissue: After the mice were euthanized, the dorsal skin tissues were embedded in OCT compound (62534, Sakura Finetek, Tokyo, Japan), after which the skin was cut into 8 μm sections using a cryostat. After 5 min of acetone fixation, the sections were washed with PBS and underwent a process of blocking, primary antibody, and secondary antibody incubation. The nuclei were stained with DAPI. The LSM900 (Zeiss, Oberkochen, Germany) was used to observe the fluorescence.

The 8-week-old female Kunming(KM) mice used in this experiment were purchased from the Animal Center of Guangdong Medical Laboratory (Guangdong, China) and were maintained on a 12-h light/dark cycle (24 ± 2 °C) with a standard rodent diet and drinking water available free of charge. The mice were acclimatized to this environment for one week. In the first part of the study, mice were divided into two groups by means of simple randomization for sampling skin and serum during the day and night (15:00 and 21:00, respectively, n = 7). In the second part, the mice were divided into three groups by simple randomization: control, sleep deprivation (SD), and SD with taurine administration (n = 7 per group). Sleep deprivation was induced using the modified multiplatform method (MMPM), a classical technique based on the principle that muscle weakness during the rapid eye movement stage of sleep causes mice to fall into water and wake up [34,35]. This method allows sleep deprivation of multiple animals simultaneously without affecting other physiological activities. The MMPM apparatus consisted of a large water tank (485 × 350 × 200 mm) containing 15 cylindrical platforms (3 cm in diameter and 5 cm in height), spaced 5 cm apart both vertically and horizontally. The platforms were elevated 1 cm above the water surface, and the tank was covered with an iron mesh to allow normal feeding. Mice were sleep-deprived from 17:00 to 11:00 the following day, with a 6-h recovery period, for a total duration of 35 days. In the SD + taurine group, beginning on the 8th day of sleep deprivation, the dorsal hair of the mice was locally removed, and 100 μM taurine (dissolved in water containing 1% carbomer) was topically applied to the depilated area. At the end of the experiment, blood samples were collected from the tail at 15:00, and orbital blood and skin tissues were collected at 21:00. Skin tissues were embedded in OCT for immunofluorescence analysis, fixed in 4% PFA for 24 h for subsequent hematoxylin-eosin, Masson's trichrome, and Sirius red staining, or frozen at −80 °C for Western blot and qRT-PCR assays. Considering the impact of physiological rhythms on estrogen levels, the estrous cycle of animals was monitored, and sampling was performed outside the estrous phase of female mice to ensure accurate results. To maintain the integrity of the blind experiment, distinct individuals were assigned to each of the following roles: group assignment, experiment execution, results evaluation, and data analysis. All animal experiments were conducted in accordance with the National Institutes of Health Animal Care and Use Guidelines and approved by the Institutional Animal Care and Use Committee of Jinan University (Approval No. IACUC-20210630-04).

FITC was dissolved in anhydrous DMSO to a concentration of 1 mg/mL, diluted to 10 μg/mL with PBS, and 400 μL of it was applied to the back of hairless mice using a sterile dressing. The whole process was protected from light. After 4 h, the mice were euthanized, and the skin tissue was embedded in OCT and sectioned at a thickness of 8 μm. The slices were fixed in acetone for 5 min, then washed with PBS and stained with DAPI for 10 min to display the cell nuclei. Finally, the slices were inspected with a fluorescence microscope (Nikon, Tokyo, Japan).

Tissue samples were embedded in paraffin and sectioned. Sections were dewaxed in xylene (15 min, twice), followed by a 1:1 mixture of xylene and anhydrous ethanol (2 min), 100% ethanol (5 min, twice), and 80% ethanol (5 min). Rehydration was completed by rinsing in distilled water for 5 min. Next, the sections were stained with hematoxylin for 5 min, rinsed in distilled water, differentiated in 1% hydrochloric acid alcohol for 30 s, and returned to blue in a weak alkaline solution. Eosin staining (0.5%) was performed for 3 min, followed by rinsing in distilled water. Then, dehydration was carried out in 80% ethanol (30 s), 95% ethanol (1 min, twice), and anhydrous ethanol (3 min, twice). Finally, the sections were immersed in xylene (3 min, twice) and sealed with neutral gum.

Paraffin sections were dewaxed in xylene three times (5 min each) and rehydrated through anhydrous ethanol, 95% ethanol, and 75% ethanol (1 min each), followed by rinsing with tap and distilled water. Sections were stained with Weigert's iron hematoxylin for 8 min, differentiated in 1% hydrochloric acid alcohol (15 s), blued with Masson blue solution (5 min), and rinsed with distilled water. The sections were stained with Masson Ponceau acid fuchsin (10 min) and washed with 2% glacial acetic acid (1 min). Differentiation was done with 1% phosphomolybdic acid (3 min), followed by rinsing in 2% glacial acetic acid, staining with aniline blue (1 min), and washing with 0.2% glacial acetic acid. Ultimately, the sections were dehydrated in ethanol, cleared in xylene, and mounted with neutral resin for microscopic examination.

Paraffin sections were dewaxed, followed by staining with iron hematoxylin for 10 min. Excess stain was removed by rinsing with distilled water. The sections were then stained with Sirius red for 20 min and gently rinsed with running water to remove excess stain. For dehydration and transparency, the sections were sequentially incubated in 75% ethanol, 95% ethanol, and anhydrous ethanol (1 min each), followed by clearing in xylene three times. The slides were covered with neutral resin and observed under a microscope.

To measure serum estradiol levels, blood samples were collected at different time points. Centrifugation at 3500× g for 15 min was used to separate the serum and plasma. As directed, an ELISA kit (Elabscience, Wuhan, China) was used to assess the serum estradiol levels.

GraphPad Prism 8's one-way ANOVA or t-test was used to evaluate mean differences, and data were displayed as mean ± standard deviation (SD) from a minimum of three independent trials. Differences were considered statistically significant at * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

To investigate whether the barrier function of the mouse epidermis is influenced by circadian rhythms, we applied FITC to the depilated back skin of female mice at 15:00 (daytime) and 21:00 (nighttime) (Figure 1A). The integrity of the skin barrier was assessed by detecting the permeability of the FITC. The results showed that FITC was more effectively blocked on the skin surface at night (21:00), suggesting superior barrier integrity, whereas its penetration was more pronounced during the day (15:00) (Figure 1B). Further investigation using immunofluorescence for the tight junction protein ZO-1 at 15:00 and 21:00 revealed that ZO-1 was more localized in the epidermal layer at night, forming a more complete barrier, while its continuity and tightness were diminished during the daytime (Figure 1C). Additionally, Western blot analysis confirmed that the expression levels of tight junction (TJ)-associated proteins ZO-1 and occludin were higher at night compared to the daytime (Figure 1D–F). In addition, Masson staining results showed that the content of collagen in the skin was significantly higher at night than during the day, indicating that the abundance of collagen was also affected by the circadian rhythm (Figure 1G,H). In order to confirm this conclusion, we detected the expression levels of collagen I and collagen III in skin tissues by Western blot. The results showed that the expression levels of collagen I and collagen III were significantly lower in the day than in the night, indicating that the abundance of collagen was influenced by circadian rhythm (Figure 1I–K). We mentioned that estradiol is an important hormone that affects skin barrier function. Interestingly, we found that the serum levels of estradiol in mice were lower during the day and higher at night, indicating that estradiol also has a certain circadian rhythm (Figure 1L).

These findings collectively suggest that both tight junction integrity and collagen content exhibit circadian rhythm-dependent fluctuations, with optimal barrier function and collagen production occurring at night. Notably, these rhythmic changes correspond with fluctuations in estradiol levels, implying that estradiol may play a crucial role in modulating epidermal barrier function and collagen synthesis.

To further investigate the role of estradiol in the formation of tight junctions and permeability in epidermal cells, we measured the trans-epithelial electrical resistance (TEER) across the epidermal cell monolayers. Given that keratinocytes are the predominant cell type in the epidermis, we treated HaCaT cell monolayers with estradiol at concentrations of 0.1 nM, 1 nM, and 10 nM. Our results indicated a significant increase in TEER values following estradiol treatment across all concentrations tested (Figure 2A). Western blot analyses also revealed that estradiol significantly upregulated the expression of ZO-1 and occludin, with the most pronounced effects observed at 1 nM and 10 nM (Figure 2B–D). Immunofluorescence results showed that after different concentrations of estradiol-treated HaCaT cells, the fluorescence intensity of barrier-related proteins ZO-1, occludin, and Claudin11 significantly increased (Figure 2E–G), indicating that estradiol can significantly promote the expression of ZO-1, occludin, and Claudin11 at the cellular level. It is suggested that estradiol has a potential role in promoting the formation of a skin barrier. In addition, in order to explore the effect of estradiol on collagen, we treated mouse fibroblasts with different concentrations of estradiol. The results showed that estradiol at 0.1 nM, 1 nM, and 10 nM significantly promoted the expression of type III collagen, while the expression of type I collagen had no significant changes (Figure 2H–J). These results suggest that estradiol is essential for the formation of collagen III.

Overall, these results suggested that the elevated estradiol levels at night enhance skin barrier integrity by promoting the expression of TJ-related proteins and the production of collagen III in mice. However, during the daytime, the estradiol levels decrease, leading to a reduced skin barrier function and decreased collagen synthesis.

In order to investigate the effect of rhythm disturbance on skin barrier function, we disrupted the rhythm of mice by subjecting them to sleep deprivation (SD) (Figure 3A). To identify whether the circadian rhythm of mouse skin is disrupted, we detected the expression changes of core clock genes Per1, Per2, and Bmal1 in skin tissue. The results showed that the mRNA levels of Per1, Per2, and Bmal1 in the Ctrl group were significantly different from those in the SD group, suggesting that the circadian rhythm in the skin of mice is disorganized (Figure 3B–D), and it is feasible to construct a mouse model of circadian disturbance through sleep deprivation. Based on the SD model, we examined changes in estradiol. The results showed that estradiol levels were lower during the daytime (15:00) and elevated at nighttime (21:00). Conversely, in SD mice, estradiol levels showed no significant fluctuations between daytime and nighttime, indicating a loss of circadian rhythm (Figure 3E). Additionally, to investigate whether the barrier function of the mouse epidermis is influenced by SD, we applied FITC to the depilated back skin of mice. After 4 h, FITC was more effectively restricted on the skin surface in the Ctrl group, suggesting enhanced barrier integrity, while its penetration was more noticeable in regions with compromised barrier continuity in the SD group, with significant penetration observed in the dermis (Figure 3F). Further, Western blot results indicated that in comparison to the Ctrl group, SD significantly reduced the expression of TJ-related proteins ZO-1 and Claudin-11, as well as type I and type III collagen in the dermis (Figure 3G–L). Masson's trichrome staining revealed distinct morphological alterations in dermal collagen architecture within the SD group. Specifically, collagen fibers exhibited a disorganized arrangement accompanied by the disruption of fibril bundle alignment, with notable fragmentation observed in localized regions. Quantitative analysis demonstrated collagen proportions were dramatically diminished compared to the control group (Figure 3M,N).

The findings indicated that sleep deprivation disrupted the circadian rhythm of estradiol, impaired the functionality of the tight junctions within the epidermal barrier, and diminished the synthesis of dermal collagen.

Since the use of exogenous estrogens may increase the risk of cancer [24], it is necessary to explore a new class of drugs to treat skin barrier damage. Taurine, an amino acid present in the skin, has been introduced into research due to its reported protective effects on skin health [30]. To ensure the safety of taurine, we conducted a CCK8 assay to evaluate its cytotoxicity at various concentrations (0.1 μM, 1 μM, and 10 μM). The results demonstrated that taurine at these concentrations had no significant impact on cell viability, thereby confirming its safety profile (Figure S1). To investigate the role of taurine in skin barrier function, HaCaT cells were treated with various concentrations of taurine (0.1 μM, 1 μM, and 10 μM) for 24 h. The results indicated that taurine at both 1 μM and 10 μM significantly increased the trans-epithelial electrical resistance (TEER) values of HaCaT monolayers, suggesting enhanced barrier integrity (Figure 4A). Western blot analysis demonstrated a significant elevation in the expression of TJ proteins, including ZO-1, occludin, and Claudin-11, at 0.1 μM, 1 μM, and 10 μM taurine (Figure 4B,C). Subsequent immunofluorescence experiments further confirmed these findings by showing increased protein expression of ZO-1 and occludin in response to taurine treatment (Figure 4D,E). Additionally, the effects of taurine on collagen production were tested in fibroblasts. Taurine significantly promoted the expression of collagen III in a dose-dependent manner (Figure 4F–H).

To examine whether taurine can restore the skin barrier compromised by estradiol deficiency, we used fulvestrant, an estradiol receptor antagonist. Our findings demonstrated that TEER values and the expression of ZO-1, occludin, and Claudin-11 were markedly reduced in the presence of both the estradiol and fulvestrant-only group, indicating compromised barrier integrity (Figure 4I,J). Notably, taurine supplementation significantly upregulated TEER values and the expression of these proteins. These results revealed that taurine can rescue the antagonistic effects of fulvestrant on estradiol, suggesting that taurine could reverse the disruption in skin barrier function caused by estradiol deficiency (Figure 4I,J).

The above findings revealed the potential of taurine to act as a substitute for estradiol in restoring tight junction protein expression and collagen production impaired by estradiol deficiency.

To further investigate whether taurine can serve as a substitute for estradiol in mitigating impairments in skin barrier function and dermal collagen synthesis induced by disruptions in the circadian rhythms of estradiol due to sleep deprivation, mice were subjected to sleep deprivation from 17:00 to 11:00 the next day, followed by a 6-h recovery period, over the course of seven days. Starting on the eighth day of sleep deprivation, a daily dorsal application of 100 μM taurine was topically administered for a total duration of 28 days (Figure 5A). At the conclusion of the 28-day treatment period, erythema and wrinkles were observed on the dorsal skin of sleep-deprived mice. In contrast, the application of taurine mitigated the appearance of erythema and wrinkle formation (Figure 5B). Then, FITC was utilized to assess skin barrier integrity. In the Ctrl group, where no treatment was applied, FITC was confined to the epidermal layer, indicating an intact skin barrier. Conversely, in the SD group, FITC penetrated into the dermis, suggesting a compromised skin barrier. However, treatment with taurine effectively prevented FITC from penetrating into the subcutaneous layer, indicating reconstruction of the skin barrier (Figure 5C).

The thickness of the epidermis layer increased from 15.27 μm in normal skin (control) to 26.42 μm in the SD groups. Notably, taurine significantly suppressed sleep deprivation-induced epidermal thickening. The epidermal thickness (17.36 μm) in the taurine treatment group resembled that of the normal control (15.27 μm) (Figure 5D,E). The thickness of the dermis layer decreased from 310.79 μm in normal skin to 232.31 μm in the SD groups. Taurine treatment significantly recovered the dermal thinning, further supporting its protective effect against sleep deprivation-induced skin damage (Figure 5D,F).

To assess the impact of taurine on collagen fibril integrity in mouse skin, Masson's trichrome staining was utilized. Sleep deprivation led to reduced collagen deposition and disrupted fiber organization. However, taurine treatment enhanced collagen alignment and increased deposition (Figure 5G,H). Further analysis with Sirius red staining and quantification of type I (orange or red) and type III (green) collagen showed a significant elevation in their proportions in the SD group compared to the control. In contrast, taurine treatment effectively restored these collagen ratios (Figure 5G,I).

We then investigated the impact of taurine on the epidermal barrier by examining the expression of skin barrier-related proteins FLG, KRT1, and KRT10 in the dorsal skin. Sleep deprivation resulted in a decrease in the mRNA levels of Flg, Krt1, and Krt10, as well as a reduction in the protein expression of ZO-1, occludin, and collagen type III. Treatment with taurine restored the mRNA levels of Flg, Krt1, and Krt10, and the protein expression of ZO-1 and occludin, as well as collagen type III, indicating its potential role in mitigating the damage induced by sleep deprivation (Figure 5J,K).

To investigate the molecular mechanisms by which taurine and estradiol enhance the skin barrier and collagen synthesis, we performed transcriptomic analysis on skin tissues from three groups: normal mice, sleep-deprived mice, and mice treated with taurine following sleep deprivation. The results revealed that 1933 genes were differentially expressed in the sleep deprivation group compared to normal mice, while 771 genes showed significant changes in the sleep deprivation group treated with taurine. Venn diagram analysis identified 512 overlapping genes between these two comparisons, and their expression patterns were visualized using a heat map (Figure 6A,B). KEGG enrichment analysis revealed that 25 genes were significantly associated with the calcium signaling pathway, ranking first among the enriched pathways, which suggested the pivotal role of taurine in calcium regulation (Figure S2).

Moreover, to identify the molecular targets of estradiol, we further treated cells with estradiol and performed quantitative mass spectrometry. This analysis identified 90 proteins with significant changes, of which 54 were upregulated and 36 were downregulated after estradiol treatment (Figure 6C). Venn diagram analysis of these 90 estradiol-responsive proteins with the 512 genes regulated by taurine treatment identified two overlapping genes: Acyp2 and Tmem38b (Figure 6D,E). Notably, TMEM38B, also known as TRIC-B, is a transmembrane protein that functions as a cation-selective channel essential for maintaining rapid intracellular calcium (Ca²⁺) release. Western blot analysis demonstrated that estradiol and taurine upregulated TMEM38B protein levels in a dose-dependent manner, with the most pronounced effects observed at concentrations of 10 nM and 10 μM, respectively (Figure 6F–I). This result indicated that TMEM38B may be a common target for both taurine and estradiol (Figure 6F–I). Immunofluorescence staining of skin tissues also showed that TMEM38B protein levels were significantly reduced in the sleep-deprived mice compared to normal mice, but taurine treatment restored TMEM38B expression to levels comparable to those in normal mice (Figure 6J). These results suggested that TMEM38B may be involved in taurine- and estradiol-regulated tight junction-related proteins and collagen expression.

Since TMEM38B plays a crucial role in regulating calcium homeostasis in cells, we examined whether TMEM38B controls calcium levels in epidermal cells and fibroblasts. We knocked down the expression of TMEM38B and stained intracellular calcium with Calbryte^TM520AM dye to monitor changes in calcium levels. Compared to the control group, cells with reduced TMEM38B expression exhibited a significant decline in intracellular calcium concentration (Figure 7A,B). In contrast, overexpression of TMEM38B significantly increased the calcium levels in epidermal cells and fibroblasts (Figure 7C,D). These results suggested that TMEM38B is involved in regulating intracellular calcium levels in epidermal cells and fibroblasts.

We then examined whether intracellular calcium levels in epidermal cells and fibroblasts participate in regulating the expression of tight junction-related proteins (ZO-1, occludin, and Claudin-11) and collagen. We found that the downregulation of ZO-1, occludin and collagen III was observed in TMEM38B-silenced cells, while their expressions were enhanced in TMEM38B-overexpressed cells (Figure 7E–L). These results suggested that TMEM38B controls intracellular calcium levels and affects tight junction-related proteins and collagen expression.

To further confirm whether TMEM38B is regulated by estradiol and taurine, we examined the levels of Tmem38b mRNA in epidermal cells and fibroblasts after treatment with either estradiol or taurine. Both estradiol and taurine significantly upregulated the expression of Tmem38b in these cell types (Figure 8A–D). Accompanying the increased expression of Tmem38b, we observed that both taurine and estradiol significantly enhanced Ca²⁺ levels in both epidermal cells and fibroblasts (Figure 8E–J).

To further elucidate the role of Ca²⁺ levels in regulating the expression of tight junction-related proteins ZO-1 and collagen, epidermal cells and fibroblasts were treated with calcium-free medium. Immunofluorescence analysis revealed that Ca²⁺ depletion significantly reduced the production of collagen III and ZO-1. In contrast, either taurine or estradiol treatments rescued the effect of calcium depletion, upregulating the expression of type III collagen and ZO-1 (Figure 8K,L).

Altogether, these results revealed taurine restored skin barrier function and mitigated collagen degradation by upregulating TMEM38B, increasing intracellular calcium ion levels, and promoting the expression of TJ-related proteins and type III collagen, thereby restoring skin homeostasis.